Evaluation of Renastep (Renastep)
Chronic Kidney Diseases, Renal Disease
About this trial
This is an interventional supportive care trial for Chronic Kidney Diseases focused on measuring Acceptability, Renal, CKD, Kidney, Vitaflo, High energy, low volume, Low potassium, Low phosphorus, Low vitamin A
Eligibility Criteria
Inclusion Criteria:
i) Diagnosis of Chronic Kidney Disease.
ii) Aged between 3 and 18 years.
iii) Has a requirement for a restricted potassium and/or restricted phosphorus diet.
iv) Has a requirement for nutrition support.
v) Freely given, written, informed consent from patient or parent/guardian.
vi) Freely given, written assent (if appropriate).
Exclusion Criteria:
i) Inability to comply with the study protocol, in the opinion of the investigator.
ii) Aged under 3 years or over 18 years.
iii) Use of additional enteral feeds during the study period, unless clinically indicated and prescribed by the investigator (must be recorded in patient case record file).
iv) Women who are pregnant / breastfeeding at the start of the study or planning to become pregnant during the study period.
Sites / Locations
- Southampton Children's Hospital
- Alder Hey Children's Hospital
- Birmingham Children's Hospital
Arms of the Study
Arm 1
Experimental
Renastep
All participants to incorporate Renastep into their usual dietary regime.